ConductScience.org, home

Paper28348554

Barriers to Radiation-Induced In Situ Tumor Vaccination.

Wennerberg E and 7 others. Front Immunol, 2017. Cited by 162 papers, by iCite.

Cite this record

ConductScience Library. Barriers to Radiation-Induced In Situ Tumor Vaccination. Papers, record 28348554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28348554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Barriers to Radiation-Induced In Situ Tumor Vaccination.
PubMed
Journal
Front Immunol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
162
iCite
Relative citation ratio, by iCite
5.37
iCite
Revised in PubMed
2021-01-03
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wennerberg EErik
2Lhuillier CClaire
3Vanpouille-Box CClaire
4Pilones KAKarsten A
5García-Martínez EElena
6Rudqvist NPNils-Petter
7Formenti SCSilvia C
8Demaria SSandra

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA201246NCI NIH HHSUnited StatesR01CA201246PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References134

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118400190Cytokine signaling modules in inflammatory responses.Immunity2008https://conductscience.org/library/papers/18400190PubMed
227660705Current clinical trials testing the combination of immunotherapy with radiotherapy.J Immunother Cancer2016https://conductscience.org/library/papers/27660705PubMed
323316199ATP release and purinergic signaling in NLRP3 inflammasome activation.Front Immunol2012https://conductscience.org/library/papers/23316199PubMed
419188147The macrophage colony-stimulating factor 1 response signature in breast carcinoma.Clin Cancer Res2009https://conductscience.org/library/papers/19188147PubMed
522087822The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).Curr Med Chem2011https://conductscience.org/library/papers/22087822PubMed
625403716Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.Cancer Immunol Res2015https://conductscience.org/library/papers/25403716PubMed
725377469Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.Cancer Res2014https://conductscience.org/library/papers/25377469PubMed
817481928T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.Immunity2007https://conductscience.org/library/papers/17481928PubMed
921586363Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity.Adv Pharmacol2011https://conductscience.org/library/papers/21586363PubMed
1016337366Colony-stimulating factor-1 in immunity and inflammation.Curr Opin Immunol2006https://conductscience.org/library/papers/16337366PubMed
1125481263Combination of radiotherapy and immune checkpoint inhibitors.Semin Radiat Oncol2015https://conductscience.org/library/papers/25481263PubMed
1224336068A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.Cancer Res2014https://conductscience.org/library/papers/24336068PubMed
1314676299Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.J Exp Med2003https://conductscience.org/library/papers/14676299PubMed
1412465600The macrophage growth factor CSF-1 in mammary gland development and tumor progression.J Mammary Gland Biol Neoplasia2002https://conductscience.org/library/papers/12465600PubMed
1516286245TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance.Cancer Cell2005https://conductscience.org/library/papers/16286245PubMed
1616551245Transforming growth factor-beta regulation of immune responses.Annu Rev Immunol2006https://conductscience.org/library/papers/16551245PubMed
1711390478A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.J Immunol2001https://conductscience.org/library/papers/11390478PubMed
1824310606NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer.Cell Tissue Res2014https://conductscience.org/library/papers/24310606PubMed
1922287455High expression of CD73 as a poor prognostic biomarker in human colorectal cancer.J Surg Oncol2012https://conductscience.org/library/papers/22287455PubMed
2027209048Immunosuppressive activities of adenosine in cancer.Curr Opin Pharmacol2016https://conductscience.org/library/papers/27209048PubMed

See all 134 referencesDownload CSV of references

Cited by118

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 162 citations.

PMIDTitleJournalYearIn PapersSource
42397620Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology.Curr Oncol Rep2026https://conductscience.org/library/papers/42397620PubMed
42332706Nrf2 deficiency converts the ESCC microenvironment into an immunologically active state via the GPX2-ICD-DC signaling path.J Transl Med2026https://conductscience.org/library/papers/42332706PubMed
42292397Neutrophil extracellular traps in tumor microenvironment for radiotherapy: friend or foe?Front Immunol2026https://conductscience.org/library/papers/42292397PubMed
42180096Complete response of a giant metastatic neck mass in tonsillar squamous cell carcinoma achieved with radiotherapy combined with immunotherapy: a case report.Front Oncol2026https://conductscience.org/library/papers/42180096PubMed
41988184Iodine-125 brachytherapy triggers immunogenic cell death and potentiates anti-PD-L1 immunotherapy in bone metastatic triple-negative breast cancer.Front Immunol2026https://conductscience.org/library/papers/41988184PubMed
40900811Cancer Immunotherapy in Combination with Radiotherapy and/or Chemotherapy: Mechanisms and Clinical Therapy.MedComm (2020)2025https://conductscience.org/library/papers/40900811PubMed
40861450Synergies between radiotherapy and immunotherapy: a systematic review from mechanism to clinical application.Front Immunol2025https://conductscience.org/library/papers/40861450PubMed
40707495The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer.NPJ Breast Cancer2025https://conductscience.org/library/papers/40707495PubMed
40583465Anti-Tumor Immunization Efficacy after Particle-Radiation Exposure.Radiat Res2025https://conductscience.org/library/papers/40583465PubMed
40453074Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity.Front Immunol2025https://conductscience.org/library/papers/40453074PubMed
40438865Combination of radiotherapy and ICIs in advanced hepatocellular carcinoma: A systematic review of current evidence and future prospects (Review).Oncol Lett2025https://conductscience.org/library/papers/40438865PubMed
40405246Carbon ion irradiation mobilizes antitumor immunity: from concept to the clinic.Radiat Oncol2025https://conductscience.org/library/papers/40405246PubMed
40247328Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy.J Hematol Oncol2025https://conductscience.org/library/papers/40247328PubMed
40236706
Radical hemithorax radiotherapy induces an increase in circulating PD-1+ T lymphocytes and in the soluble levels of PD-L1 in malignant pleural mesothelioma patients: a possible synergy with PD-1/PD-L1 targeting treatment?
Front Immunol2025https://conductscience.org/library/papers/40236706PubMed
40223683In Situ Cancer Vaccines: Redefining Immune Activation in the Tumor Microenvironment.ACS Biomater Sci Eng2025https://conductscience.org/library/papers/40223683PubMed
39872847CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies.Front Cell Dev Biol2024https://conductscience.org/library/papers/39872847PubMed
39308864Immunological signatures from irradiated cancer-associated fibroblasts.Front Immunol2024https://conductscience.org/library/papers/39308864PubMed
38853541Role of HIF-1α in the Responses of Tumors to Radiotherapy and Chemotherapy.Cancer Res Treat2025https://conductscience.org/library/papers/38853541PubMed
38773258Combination of proton- or X-irradiation with anti-PDL1 immunotherapy in two murine oral cancers.Sci Rep2024https://conductscience.org/library/papers/38773258PubMed
38488488Radiation-induced effects on TGF-β and PDGF receptor signaling in cancer-associated fibroblasts.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/38488488PubMed

See all 118 cited byDownload CSV of cited by

Genes27

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ADORA2A135PubTator's text mininghttps://conductscience.org/library/genes/135NCBI Gene
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
CCL26347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
CCR2729230PubTator's text mininghttps://conductscience.org/library/genes/729230NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CSF11435PubTator's text mininghttps://conductscience.org/library/genes/1435NCBI Gene
CSF1R1436PubTator's text mininghttps://conductscience.org/library/genes/1436NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
CXCL103627PubTator's text mininghttps://conductscience.org/library/genes/3627NCBI Gene
CXCL1658191PubTator's text mininghttps://conductscience.org/library/genes/58191NCBI Gene
ENTPD1953PubTator's text mininghttps://conductscience.org/library/genes/953NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL183606PubTator's text mininghttps://conductscience.org/library/genes/3606NCBI Gene
IL1B3553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene

See all 27 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28348554

GET https://conductscience.org/api/papers/v1/28348554/references?page=2